KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Income from Non-Controlling Interests (2016 - 2025)

Omega Healthcare Investors' Income from Non-Controlling Interests history spans 7 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Income from Non-Controlling Interests rose 128.46% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $19.3 million, up 67.99%, while the annual FY2025 figure was $19.3 million, 67.99% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was $7.1 million at Omega Healthcare Investors, up from $5.2 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $7.1 million in Q4 2025 and bottomed at $903000.0 in Q1 2023.
  • The 5-year median for Income from Non-Controlling Interests is $2.9 million (2022), against an average of $3.0 million.
  • The largest annual shift saw Income from Non-Controlling Interests surged 256.96% in 2021 before it tumbled 83.73% in 2023.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $947000.0 in 2021, then grew by 19.01% to $1.1 million in 2022, then soared by 34.96% to $1.5 million in 2023, then surged by 105.39% to $3.1 million in 2024, then surged by 128.46% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Income from Non-Controlling Interests are $7.1 million (Q4 2025), $5.2 million (Q3 2025), and $3.9 million (Q2 2025).